Company / Profit Margin
Ligand Pharmaceuticals, Inc. Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
46.4%
FY2025
5-year range
-17.0% / 46.4%
FY2021-FY2025
Trend
+2026.1%
vs FY2024
Sector context
#8 of 146
Health Care
What the data says
Profit Margin changed +2026% YoY in FY2025, a notable deviation from the 9-year average annual change of +799%.
Based on SEC 10-K filings.
46.4% in FY2025 with a 5-year CAGR of +48.2%. Top quartile in the Health Care sector.
Improved from 39.7% to 46.4% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +63.4pp
- 5-Year Change
- +48.2pp
- 10-Year Change
- -
Sector benchmark
Top 5% in Health CareTop 5% of 146This company 46.4% Sector average -796.3%
▼
+105.8% above sector average
Key checks
Key Insights
- In FY2025, profit margin increased 2026.1% year-over-year.
- Currently 842.7pp above the Health Care sector average.
- Peak profit margin was recorded in FY2019.
- Lowest profit margin in the period was in FY2022.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 46.4% | +2026.1% |
| FY2024 | -2.4% | -106.1% |
| FY2023 | 39.7% | +333.6% |
| FY2022 | -17.0% | -171.9% |
| FY2021 | 23.7% | +1400.0% |
| FY2020 | -1.8% | -100.3% |
| FY2019 | 523.2% | +817.9% |
| FY2018 | 57.0% | +32.9% |
| FY2017 | 42.9% | +2960.0% |
| FY2016 | -1.5% | -100.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026